Scribd Logo
Upload

Welcome to Scribd!

  • List of Anti Cancer Drugs 3 August 2015 FINAL - PDF 62412275

    Uploaded by

    Gopalkrishna Iyer
    28 views4 pages
    This document provides two lists of anti-cancer drugs: List A drugs are expected to be covered in clinical oncology training and may be included in the clinical pharmacology exam, while List B drugs will not be examined but may be covered in the final exam. The document states the drugs from major classes that trainees are expected to demonstrate knowledge of and notes that the list will be regularly reviewed to ensure it reflects current practice.

    Original Description:

    Original Title

    List_of_anti_cancer_drugs_3_August_2015_FINAL.pdf_62412275

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This document provides two lists of anti-cancer drugs: List A drugs are expected to be covered in clinical oncology training and may be included in the clinical pharmacology exam, while List B drugs will not be examined but may be covered in the final exam. The document states the drugs from major classes that trainees are expected to demonstrate knowledge of and notes that the list will be regularly reviewed to ensure it reflects current practice.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    28 views4 pages

    List of Anti Cancer Drugs 3 August 2015 FINAL - PDF 62412275

    Uploaded by

    Gopalkrishna Iyer
    This document provides two lists of anti-cancer drugs: List A drugs are expected to be covered in clinical oncology training and may be included in the clinical pharmacology exam, while List B drugs will not be examined but may be covered in the final exam. The document states the drugs from major classes that trainees are expected to demonstrate knowledge of and notes that the list will be regularly reviewed to ensure it reflects current practice.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 4

    First FRCR Examination – Clinical Pharmacology module

    List of Anti-Cancer Drugs

    This supporting document sets out a list of drugs expected to be covered during core clinical
    oncology training and which may be included in the clinical pharmacology module of the
    First FRCR examination. It is anticipated that this will be reviewed regularly to ensure current
    practice is reflected.

    List A contains drugs from all the major classes. Trainees are expected to demonstrate their
    knowledge of these drugs in terms of their indications, and all aspects of these drugs as
    defined in Appendix 2 of the specialty training curriculum - “Underpinning Scientific
    Principles” (Appendix 2, sections 2.1-2.5 and 2.7).

    List B drugs will not be examined in the First FRCR Examination but may feature in the Final
    FRCR Examination as defined in Appendix 1 of the curriculum.

    This version will apply to examinations held from Autumn 2016 until a further version is
    published.

    LIST A
    Cytotoxic agents

    Alkylating agents
    • Cyclophosphamide
    • Ifosfamide
    • Temozolomide
    Anti- Metabolites
    • Capecitabine
    • 5- Fluoro Uracil
    • Methotrexate
    • Gemcitabine
    • Pemetrexed

    Anti-Tumour Antibiotics
    • Mitomycin
    • Bleomycin
    • Epirubicin
    • Doxorubicin (pegylated liposomal)

    3 August 2015 - p1
    Plant Alkaloids/ Microtubule Inhibitors
    • Etoposide
    • Paclitaxel
    • Irinotecan
    • Docetaxel
    • Vincristine

    DNA Linking Agents


    • Carboplatin
    • Cisplatin
    • Oxaliplatin

    Biological agents
    • Bevacizumab
    • Cetuximab
    • Gefitinib
    • Imatinib
    • Trastuzumab
    • Denosumab
    • Rituximab
    • Sunitinib

    Bisphosphonates
    • Zoledronate

    Hormones/other
    • Abiraterone
    • Anastrozole
    • Bicalutamide
    • Exemestane
    • Goserelin
    • Medroxyprogesterone
    • Octreotide
    • Tamoxifen

    2015 Page 2 of 4
    LIST B
    Cytotoxic agents

    Alkylating agents
    • Bendamustine
    • Carmustine
    • Chlorambucil
    • Lomustine
    • Melphalan
    • Procarbazine
    • Streptozocin
    Anti- Metabolites
    • Fludarabine
    • Raltitrexed
    Anti-Tumour Antibiotics
    • Actinomycin D / Dactinomycin
    • Doxorubicin
    • Mitoxantrone

    Plant Alkaloids/ Microtubule Inhibitors


    • Eribulin
    • Topotecan
    • Vinblastine
    • Vinorelbine

    Biological agents
    • Afatinib
    • Aflibercept
    • BCG
    • Crizotinib
    • Dabrafenib
    • Interferon
    • Ipilimumab
    • Lapatinib
    • Nivolumab
    • Panitumumab

    2015 Page 3 of 4
    • Pembrolizumab
    • Pertuzumab
    • Sorafenib
    • Trastuzumab emtansine
    • Temsirolimus
    • Vemurafenib

    Bisphosphonates
    • Ibandronic acid
    • Pamidronate

    Hormones/other
    • Bexarotene
    • Buserelin
    • Cyproterone
    • Degarelix
    • Folinic acid
    • Fulvestrant
    • Lanreotide
    • Lenalidomide
    • Letrozole
    • Leuprorelin
    • Megestrol
    • Mesna
    • Thalidomide

    2015 Page 4 of 4

    You might also like